Wed, 23 May 2018 15:10:04 GMT
Cara Therapeutics shares rise on deal with Fresenius
On Wednesday, shares of Cara Therapeutics soared more than 20%, as it had signed a licensing deal with Vitor Fresenius that could provide the US drug maker with up to $470M in milestone payments.